Evaluation of the website of the ...
Document type :
Article dans une revue scientifique: Article original
PMID :
Permalink :
Title :
Evaluation of the website of the nord-pas-de-calais regional pharmacovigilance center
Author(s) :
Rochoy, Michael [Auteur]
Bene, Johana [Auteur]
Messaadi, Nassir [Auteur]
Auffret, Marine [Auteur]
Gautier, Sophie [Auteur]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U1171
Bene, Johana [Auteur]
Messaadi, Nassir [Auteur]
Auffret, Marine [Auteur]
Gautier, Sophie [Auteur]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U1171
Journal title :
Therapie
Abbreviated title :
Therapie
Volume number :
71
Pages :
329-333
Publication date :
2016-06-01
ISSN :
0040-5957
English keyword(s) :
Internet
Information dissemination
Pharmacovigitance
General practice
Social media
Information dissemination
Pharmacovigitance
General practice
Social media
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
We posted the Nord-Pas-de-Calais regional pharmacovigilance center website and distributed a survey to its potential users between August 2014 and October 2014 (135 general practitioners, 45 pharmacists, 14 patients). ...
Show more >We posted the Nord-Pas-de-Calais regional pharmacovigilance center website and distributed a survey to its potential users between August 2014 and October 2014 (135 general practitioners, 45 pharmacists, 14 patients). Satisfaction was 7.3±1.6 out of 10 points for the visual aspect, 7.8±1.5 out of 10 points for navigation and 7.6±1.4 out of 10 points for content. The website was declared useful by 98% respondents, particularly for the reporting of adverse drugs reactions (89%).Show less >
Show more >We posted the Nord-Pas-de-Calais regional pharmacovigilance center website and distributed a survey to its potential users between August 2014 and October 2014 (135 general practitioners, 45 pharmacists, 14 patients). Satisfaction was 7.3±1.6 out of 10 points for the visual aspect, 7.8±1.5 out of 10 points for navigation and 7.6±1.4 out of 10 points for content. The website was declared useful by 98% respondents, particularly for the reporting of adverse drugs reactions (89%).Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
CNRS
Inserm
Université de Lille
CNRS
Inserm
Université de Lille
Collections :
Research team(s) :
Troubles cognitifs dégénératifs et vasculaires
Submission date :
2019-11-27T13:02:49Z